Replies to post #307822 on NorthWest Biotherapeutics Inc (NWBO)

[tryn2]

Marzan wrote:”Hopefully TLD release will keep us above $1 in the next few weeks so that we can be at Nasdaq by 11/20/20.”

Hey Marz, thought l read on the board that it takes an excess of $4 pps for over a month to qualify.... l have no clue if this is correct... is it $4 for over a month or is this fud..,???

[Dan88]

marzan I believe we don't need to go through the usual Nasdaq listing process/procedures as we are former Nasdaq listed company and it seems very clear Linda has been preparing for uplisting/back to Nasdaq for some time. The recent up-to-date filing is evidence.

After positive topline data which will be announced within two weeks, there will be no obstacle to go back to Nasdaq. For instance, no investors will complain to have a reverse slit of stock 1 for 4 or 1 for 10 to make the stock price to $4 or $10 per piece if the stock price is $1.

I personally think if the results are positive enough, the stock price will be well above 1 and may readily reach $4 and $5 in a short time thanks to the current general crazy market environment and widespread awareness of humans own immunization system which can do wonder.

GLTY and GLTA longs.

[With short squeeze which we are definitely having one, big or small, the share price may easily go above $10 in a few days]

[Sharkee2]

Marzan, here are the listing requirements per investopedia for NASDAQ:

Listing Requirements for All Companies
Each company must have a minimum of 1,250,000 publicly traded shares upon listing, excluding those held by officers, directors or any beneficial owners of more than 10% of the company.
Also, the regular bid price at the time of listing must be $4.00, and there must be at least three market makers for the stock.
However, a company may qualify under a closing price alternative of $3.00 or $2.00 if the company meets varying requirements.
Each listing firm is also required to follow NASDAQ corporate governance rules 4350, 4351 and 4360.
Companies must also have at least 450 round lot (100 shares) shareholders, 2,200 total shareholders, or 550 total shareholders with 1.1 million average trading volume over the past 12 months.